Physician

Daniel Benson, D.O.

According to 2025 Medicare claims, Daniel Benson, D.O. (NPI: 1851770465) practices family practice in the Niles, MI market, with the plurality of this provider's patient population coming from Berrien, MI. This provider's primary affiliated billing organization is LAKELAND MEDICAL PRACTICES (NPI: 1538397120; TIN: 270381199) and primary practice location at 49085-9513. Benson is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Benson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 259 traditional Medicare patients, billed 3,295 HCPCS/CPT codes, and received $73,974 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,352 prescription claims across 516 beneficiaries totaling $982,254 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 31 claims. Open Payments data shows 6 records totaling $117. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $40,868 and ending at $73,974. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $12,813 to $982,254. In contrast, DME billing represents a smaller volume and rose steadily, from $2,991 to $12,477.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	212	1,492	$40,868
2019	362	5,035	$83,691
2020	355	5,110	$76,775
2021	374	6,962	$70,661
2022	323	6,730	$53,830
2023	278	1,967	$40,602
2024	259	3,295	$73,974

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	25	124	$12,813
2016	121	655	$45,052
2017	133	1,432	$100,552
2018	325	2,031	$176,024
2019	460	5,539	$525,976
2020	515	6,774	$676,514
2021	634	9,371	$886,587
2022	626	9,128	$1,021,070
2023	563	8,849	$1,156,992
2024	516	8,352	$982,254

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	36	$4,281
2019	N/R	38	$778
2020	N/R	28	$575
2021	15	85	$5,472
2022	N/R	72	$11,388
2023	N/R	50	$9,962
2024	N/R	31	$8,802

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	208	208	$131
90653	Influenza vaccine, inactivated	23	23	$82
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	203	352	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	119	159	$52
G0008	Administration of influenza virus vaccine	27	27	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	126	7,720	$141,396
Jardiance	Empagliflozin	102	6,790	$124,862
Mounjaro	Tirzepatide	60	2,408	$85,975
Eliquis	Apixaban	71	4,500	$84,037
Ozempic	Semaglutide	56	2,076	$66,876

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	19	$7,682
A4424	Ostomy pouch, drainable, with barrier attached, with filter (1 piece), each	N	N/R	12	$1,120

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$117	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Benson, D.O.?

Tedicare shows public-source Medicare data for Daniel Benson, D.O. (NPI 1851770465), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Benson, D.O. have ACO affiliation data?

Daniel Benson, D.O. is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Daniel Benson, D.O.?

Daniel Benson, D.O. is linked to LAKELAND MEDICAL PRACTICES (billing NPI 1538397120) in the available physician profile data.

Does Daniel Benson, D.O. have Open Payments data?

Daniel Benson, D.O. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.